Our mission as Exploitant

early access

compassionate access

licensed

Offering integrated continuum services for

medicinal products to access the french market.

All In One Services

Pharmaceutical tailored-made services to access the French market


Early Access Programs | Compassionate Use | Secondary packaging & Batch Release | Distribution | Promotion & Sales | Market Access | Pharmacovigilance & Medical information

 

Loading...

Cevidra at a glance

0
Years of Experience
0+
Hospitals delivered by Cevidra
0%
Delivery Success Rate

Exploitant | Distributor | Manufacturer | Importer

Our expertise

Since its creation, Cevidra has specialized in the regulatory and operational support of the marketing of high value-added drugs intended for hospital use, especially in blood-derived products, innovative biotechnology/ATMPs, and orphan drugs.

Pills-closePills-open

Blood-derived products

Blood-derived products require specific regulations and traceability without fail. Cevidra is able to manage their distribution brilliantly.

Learn More

Biotech & ATMP

Major assets of medical innovation, biotechnology products and cell and gene therapies called ATMPs are on the rise.

Read More

Orphan drugs & rare diseases

The main unmet medical needs remain rare diseases. Cevidra helps to develop these therapies for the French market.

Read More

Hospital market

Being in Cevidra’s DNA, the expertise of the hospital market and public tenders helps our partners to expand their market share.

Read More

Regulatory compliance

Drowning in French regulations? Do not hesitate to contact Cevidra to guide you and accelerate your pipeline.

Read More

Our NETWORKS

Careers

We are a team of diverse, driven and passionate people working together to bring innovation to all patients in France.